Next Article in Journal
Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants
Next Article in Special Issue
Mutual Balance between Vasohibin-1 and Soluble VEGFR-1 in Endothelial Cells
Previous Article in Journal
Oral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of ActionOral Hypoglycemic Drugs: Pathophysiological Basis of Their Mechanism of Action
Previous Article in Special Issue
Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action
Open AccessReview

Article Versions Notes

Pharmaceuticals 2010, 3(10), 3021-3039; https://doi.org/10.3390/ph3103021
Action Date Notes Link
article xml file uploaded 5 June 2014 08:48 CEST Update https://www.mdpi.com/1424-8247/3/10/3021/xml
article html file updated 5 June 2014 08:49 CEST Update https://www.mdpi.com/1424-8247/3/10/3021/html
article html file updated 16 June 2015 11:55 CEST Update https://www.mdpi.com/1424-8247/3/10/3021/html
article html file updated 20 March 2019 03:16 CET Update https://www.mdpi.com/1424-8247/3/10/3021/html
article html file updated 9 May 2019 04:12 CEST Update https://www.mdpi.com/1424-8247/3/10/3021/html
article html file updated 5 February 2020 15:33 CET Update https://www.mdpi.com/1424-8247/3/10/3021/html
Back to TopTop